Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEStatement of deviation(s) or variation(s) under Reg. 32Results27 Jul 2026

Emkay Global Financial Services Limited

Statement of deviation(s) or variation(s) under Reg. 32

Emkay Global Financial Services Limited has informed the Exchange about the outcome of its Board Meeting held on 27th July, 2026, where the Board approved the unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026, along with the Limited Review Report issued by the Statutory Auditor.

Read more →📎 1 attachment
BSECompany UpdateResults27 Jul 2026

Senores Pharmaceuticals Ltd

Senores Pharmaceuticals Limited has informed the Exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended June 30, 2026

Senores Pharmaceuticals Ltd has submitted a statement of deviation or variation in utilisation of funds of public issue for the quarter ended June 30, 2026, indicating no deviation or variation in the utilization of proceeds of IPO.

Read more →📎 1 attachment
NSEGeneral UpdatesResults27 Jul 2026

Emkay Global Financial Services Limited

General Updates

Emkay Global Financial Services Limited has informed the Exchange about the outcome of its Board Meeting for the quarter ended 30th June, 2026, where the Board approved the unaudited standalone and consolidated financial results for the quarter.

Read more →📎 1 attachment
BSEOthersResults27 Jul 2026

Mysore Petro Chemicals Ltd-$

Corrigendum to Annual Report for the FY 2025-26

Mysore Petro Chemicals Ltd has issued a corrigendum to its Annual Report for FY 2025-26, correcting typographical errors in the report. The corrections include changes to page numbers and figures. The revised report is being disseminated electronically to shareholders. The company has also announced its 56th Annual General Meeting, scheduled for August 11, 2026, to consider the audited financial statements, dividend declaration, and director appointment.

Read more →📎 1 attachment
NSEStatement of deviation(s) or variation(s) under Reg. 32Results27 Jul 2026

Senores Pharmaceuticals Limited

Statement of deviation(s) or variation(s) under Reg. 32

Senores Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 for the quarter ended June 30, 2026. The company has confirmed that there has been no deviation(s) or variation(s) in the utilization of proceeds of IPO for the mentioned period. However, there is a delay in the going concern principle for investment in one of our subsidiaries, Havix, to fund deployment of capital of funds expenditure under requirements for setting up a manufacturing company facility for the production of sterile injections in our Atlanta facility.

Read more →📎 1 attachment
NSEShareholders meetingResults27 Jul 2026

Pokarna Limited

Shareholders meeting

Pokarna Limited has submitted the Exchange a copy of the Scrutinizer's report of the Annual General Meeting held on July 27, 2026, and informed the Exchange regarding voting results.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults27 Jul 2026

Gravita India Limited

Investor Presentation

Gravita India Limited has informed the Exchange about Investor Presentation, highlighting its growth trajectory in Q1FY27 with YoY growth of 42% in revenue, 29% in EBITDA, and 14% in PAT. The Company expanded its Phagi lead recycling capacity and received the London Metal Exchange (LME) Brand Listing for its lead metal.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults27 Jul 2026

Gravita India Ltd

Please find enclosed investor presentation of the Company for the Quarter ended 30th June 2026

Gravita India Ltd submitted an investor presentation for the quarter ended 30th June 2026, highlighting a 42% YoY growth in revenue, 29% in EBITDA, and 14% in PAT. The company expanded its lead recycling capacity and received the London Metal Exchange (LME) Brand Listing for its lead metal. ICRA Limited upgraded the company's credit rating.

Read more →📎 1 attachment
NSEStatement of deviation(s) or variation(s) under Reg. 32Results27 Jul 2026

Northern Arc Capital Limited

Statement of deviation(s) or variation(s) under Reg. 32

Northern Arc Capital Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, confirming that there was no deviation or variation in the utilisation of proceeds raised through issuance of equity shares by way of Initial Public offer for the first quarter ended June 30, 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults27 Jul 2026

Emkay Global Financial Services Ltd

Outcome of Board Meeting dated 27th July, 2026

Emkay Global Financial Services Ltd has announced the outcome of its board meeting held on 27th July, 2026. The board has approved the unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026. The results along with the limited review report issued by the statutory auditor, M/s. S. R. Batliboi & Co. LLP, are enclosed. The meeting concluded at 5:30 p.m.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults27 Jul 2026

Emkay Global Financial Services Limited

Outcome of Board Meeting

Emkay Global Financial Services Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as per the requirements of Regulation 33 and Regulation 52 of the SEBI Listing Regulations. The results have been approved by the Board of Directors, and the company has also disclosed various information as per the regulations.

Read more →📎 1 attachment
BSEBoard MeetingResults27 Jul 2026

Igarashi Motors India Ltd

Igarashi Motors India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve This has reference to ....

Igarashi Motors India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 to consider and approve the unaudited financial results for the first quarter ended June 30, 2026 as per IndAS.

Read more →📎 1 attachment
BSEResultResults27 Jul 2026

Godfrey Phillips India Ltd

Unaudited Financial Results for the quarter ended 30th June 2026.

Godfrey Phillips India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and the statutory auditors conducting a limited review. The company has also fixed August 11, 2026, as the record date for the payment of final dividend for the financial year 2025-26 and has convened its 89th Annual General Meeting on August 24, 2026.

Read more →📎 1 attachment
← PreviousPage 1999 of 2388Next →